Non-steroidal antioestrogens: molecular pharmacology and antitumour activity
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Sydney u.a.
Academic Pr.
1981
|
| Schriftenreihe: | Ludwig symposia
1. |
| Schlagworte: | |
| Beschreibung: | XXII, 496 S. graph. Darst. |
| ISBN: | 0126778809 |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV007600818 | ||
| 003 | DE-604 | ||
| 005 | 20050131 | ||
| 007 | t | ||
| 008 | 930421s1981 d||| |||| 00||| eng d | ||
| 020 | |a 0126778809 |9 0-12-677880-9 | ||
| 035 | |a (OCoLC)8449808 | ||
| 035 | |a (DE-599)BVBBV007600818 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 |a DE-355 |a DE-188 | ||
| 050 | 0 | |a RC280.B8 | |
| 082 | 0 | |a 616.99/449061 |2 19 | |
| 084 | |a VS 9100 |0 (DE-625)147725:253 |2 rvk | ||
| 245 | 1 | 0 | |a Non-steroidal antioestrogens |b molecular pharmacology and antitumour activity |c Hrsg. von Robert L. Sutherland* |
| 264 | 1 | |a Sydney u.a. |b Academic Pr. |c 1981 | |
| 300 | |a XXII, 496 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Ludwig symposia |v 1. | |
| 650 | 4 | |a Anti-strogènes - Effets physiologiques | |
| 650 | 4 | |a Anti-strogènes - Essais | |
| 650 | 4 | |a Sein - Cancer - Chimiothérapie | |
| 650 | 4 | |a Tamoxifène | |
| 650 | 4 | |a Breast Neoplasms |x drug therapy |v Congresses | |
| 650 | 4 | |a Breast |x Cancer |x Endocrine aspects | |
| 650 | 4 | |a Estrogen Antagonists |v Congresses | |
| 650 | 4 | |a Estrogen |x Antagonists |x Physiological effect | |
| 650 | 4 | |a Estrogen |x Antagonists |x Testing | |
| 650 | 4 | |a Estrogens, Non-Steroidal |v Congresses | |
| 650 | 4 | |a Molecular pharmacology | |
| 650 | 4 | |a Tamoxifen | |
| 650 | 4 | |a Tamoxifen |v Congresses | |
| 650 | 0 | 7 | |a Chemotherapie |0 (DE-588)4127083-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Antiöstrogene |0 (DE-588)4142728-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Tumor |0 (DE-588)4078460-5 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Brustkrebs |0 (DE-588)4008528-4 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Inhibitor |0 (DE-588)4027007-5 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
| 689 | 0 | 0 | |a Antiöstrogene |0 (DE-588)4142728-2 |D s |
| 689 | 0 | 1 | |a Brustkrebs |0 (DE-588)4008528-4 |D s |
| 689 | 0 | 2 | |a Inhibitor |0 (DE-588)4027007-5 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Tumor |0 (DE-588)4078460-5 |D s |
| 689 | 1 | 1 | |a Chemotherapie |0 (DE-588)4127083-6 |D s |
| 689 | 1 | |5 DE-604 | |
| 689 | 2 | 0 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
| 689 | 2 | 1 | |a Chemotherapie |0 (DE-588)4127083-6 |D s |
| 689 | 2 | |5 DE-604 | |
| 689 | 3 | 0 | |a Antiöstrogene |0 (DE-588)4142728-2 |D s |
| 689 | 3 | 1 | |a Brustkrebs |0 (DE-588)4008528-4 |D s |
| 689 | 3 | 2 | |a Chemotherapie |0 (DE-588)4127083-6 |D s |
| 689 | 3 | |5 DE-604 | |
| 700 | 1 | |a Sutherland, Robert L. |e Sonstige |0 (DE-588)129741159 |4 oth | |
| 830 | 0 | |a Ludwig symposia |v 1. |w (DE-604)BV006663437 |9 1 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-004968338 | ||
| 980 | 4 | |a (DE-12)AK690548 | |
| 980 | 4 | |a (DE-12)AK21640571 | |
Datensatz im Suchindex
| _version_ | 1804121913712181248 |
|---|---|
| any_adam_object | |
| author_GND | (DE-588)129741159 |
| building | Verbundindex |
| bvnumber | BV007600818 |
| callnumber-first | R - Medicine |
| callnumber-label | RC280 |
| callnumber-raw | RC280.B8 |
| callnumber-search | RC280.B8 |
| callnumber-sort | RC 3280 B8 |
| callnumber-subject | RC - Internal Medicine |
| classification_rvk | VS 9100 |
| ctrlnum | (OCoLC)8449808 (DE-599)BVBBV007600818 |
| dewey-full | 616.99/449061 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.99/449061 |
| dewey-search | 616.99/449061 |
| dewey-sort | 3616.99 6449061 |
| dewey-tens | 610 - Medicine and health |
| discipline | Chemie / Pharmazie Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02707nam a2200745 cb4500</leader><controlfield tag="001">BV007600818</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20050131 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">930421s1981 d||| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0126778809</subfield><subfield code="9">0-12-677880-9</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)8449808</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV007600818</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-188</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC280.B8</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.99/449061</subfield><subfield code="2">19</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VS 9100</subfield><subfield code="0">(DE-625)147725:253</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Non-steroidal antioestrogens</subfield><subfield code="b">molecular pharmacology and antitumour activity</subfield><subfield code="c">Hrsg. von Robert L. Sutherland*</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Sydney u.a.</subfield><subfield code="b">Academic Pr.</subfield><subfield code="c">1981</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XXII, 496 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Ludwig symposia</subfield><subfield code="v">1.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Anti-strogènes - Effets physiologiques</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Anti-strogènes - Essais</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Sein - Cancer - Chimiothérapie</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Tamoxifène</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Breast Neoplasms</subfield><subfield code="x">drug therapy</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Breast</subfield><subfield code="x">Cancer</subfield><subfield code="x">Endocrine aspects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Estrogen Antagonists</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Estrogen</subfield><subfield code="x">Antagonists</subfield><subfield code="x">Physiological effect</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Estrogen</subfield><subfield code="x">Antagonists</subfield><subfield code="x">Testing</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Estrogens, Non-Steroidal</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Molecular pharmacology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Tamoxifen</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Tamoxifen</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Chemotherapie</subfield><subfield code="0">(DE-588)4127083-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Antiöstrogene</subfield><subfield code="0">(DE-588)4142728-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Tumor</subfield><subfield code="0">(DE-588)4078460-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Brustkrebs</subfield><subfield code="0">(DE-588)4008528-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Inhibitor</subfield><subfield code="0">(DE-588)4027007-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Antiöstrogene</subfield><subfield code="0">(DE-588)4142728-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Brustkrebs</subfield><subfield code="0">(DE-588)4008528-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Inhibitor</subfield><subfield code="0">(DE-588)4027007-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Tumor</subfield><subfield code="0">(DE-588)4078460-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Chemotherapie</subfield><subfield code="0">(DE-588)4127083-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Chemotherapie</subfield><subfield code="0">(DE-588)4127083-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="3" ind2="0"><subfield code="a">Antiöstrogene</subfield><subfield code="0">(DE-588)4142728-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2="1"><subfield code="a">Brustkrebs</subfield><subfield code="0">(DE-588)4008528-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2="2"><subfield code="a">Chemotherapie</subfield><subfield code="0">(DE-588)4127083-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sutherland, Robert L.</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)129741159</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Ludwig symposia</subfield><subfield code="v">1.</subfield><subfield code="w">(DE-604)BV006663437</subfield><subfield code="9">1</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-004968338</subfield></datafield><datafield tag="980" ind1="4" ind2=" "><subfield code="a">(DE-12)AK690548</subfield></datafield><datafield tag="980" ind1="4" ind2=" "><subfield code="a">(DE-12)AK21640571</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift gnd-content |
| genre_facet | Konferenzschrift |
| id | DE-604.BV007600818 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T17:05:32Z |
| institution | BVB |
| isbn | 0126778809 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-004968338 |
| oclc_num | 8449808 |
| open_access_boolean | |
| owner | DE-12 DE-355 DE-BY-UBR DE-188 |
| owner_facet | DE-12 DE-355 DE-BY-UBR DE-188 |
| physical | XXII, 496 S. graph. Darst. |
| publishDate | 1981 |
| publishDateSearch | 1981 |
| publishDateSort | 1981 |
| publisher | Academic Pr. |
| record_format | marc |
| series | Ludwig symposia |
| series2 | Ludwig symposia |
| spelling | Non-steroidal antioestrogens molecular pharmacology and antitumour activity Hrsg. von Robert L. Sutherland* Sydney u.a. Academic Pr. 1981 XXII, 496 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier Ludwig symposia 1. Anti-strogènes - Effets physiologiques Anti-strogènes - Essais Sein - Cancer - Chimiothérapie Tamoxifène Breast Neoplasms drug therapy Congresses Breast Cancer Endocrine aspects Estrogen Antagonists Congresses Estrogen Antagonists Physiological effect Estrogen Antagonists Testing Estrogens, Non-Steroidal Congresses Molecular pharmacology Tamoxifen Tamoxifen Congresses Chemotherapie (DE-588)4127083-6 gnd rswk-swf Antiöstrogene (DE-588)4142728-2 gnd rswk-swf Krebs Medizin (DE-588)4073781-0 gnd rswk-swf Tumor (DE-588)4078460-5 gnd rswk-swf Brustkrebs (DE-588)4008528-4 gnd rswk-swf Inhibitor (DE-588)4027007-5 gnd rswk-swf (DE-588)1071861417 Konferenzschrift gnd-content Antiöstrogene (DE-588)4142728-2 s Brustkrebs (DE-588)4008528-4 s Inhibitor (DE-588)4027007-5 s DE-604 Tumor (DE-588)4078460-5 s Chemotherapie (DE-588)4127083-6 s Krebs Medizin (DE-588)4073781-0 s Sutherland, Robert L. Sonstige (DE-588)129741159 oth Ludwig symposia 1. (DE-604)BV006663437 1 |
| spellingShingle | Non-steroidal antioestrogens molecular pharmacology and antitumour activity Ludwig symposia Anti-strogènes - Effets physiologiques Anti-strogènes - Essais Sein - Cancer - Chimiothérapie Tamoxifène Breast Neoplasms drug therapy Congresses Breast Cancer Endocrine aspects Estrogen Antagonists Congresses Estrogen Antagonists Physiological effect Estrogen Antagonists Testing Estrogens, Non-Steroidal Congresses Molecular pharmacology Tamoxifen Tamoxifen Congresses Chemotherapie (DE-588)4127083-6 gnd Antiöstrogene (DE-588)4142728-2 gnd Krebs Medizin (DE-588)4073781-0 gnd Tumor (DE-588)4078460-5 gnd Brustkrebs (DE-588)4008528-4 gnd Inhibitor (DE-588)4027007-5 gnd |
| subject_GND | (DE-588)4127083-6 (DE-588)4142728-2 (DE-588)4073781-0 (DE-588)4078460-5 (DE-588)4008528-4 (DE-588)4027007-5 (DE-588)1071861417 |
| title | Non-steroidal antioestrogens molecular pharmacology and antitumour activity |
| title_auth | Non-steroidal antioestrogens molecular pharmacology and antitumour activity |
| title_exact_search | Non-steroidal antioestrogens molecular pharmacology and antitumour activity |
| title_full | Non-steroidal antioestrogens molecular pharmacology and antitumour activity Hrsg. von Robert L. Sutherland* |
| title_fullStr | Non-steroidal antioestrogens molecular pharmacology and antitumour activity Hrsg. von Robert L. Sutherland* |
| title_full_unstemmed | Non-steroidal antioestrogens molecular pharmacology and antitumour activity Hrsg. von Robert L. Sutherland* |
| title_short | Non-steroidal antioestrogens |
| title_sort | non steroidal antioestrogens molecular pharmacology and antitumour activity |
| title_sub | molecular pharmacology and antitumour activity |
| topic | Anti-strogènes - Effets physiologiques Anti-strogènes - Essais Sein - Cancer - Chimiothérapie Tamoxifène Breast Neoplasms drug therapy Congresses Breast Cancer Endocrine aspects Estrogen Antagonists Congresses Estrogen Antagonists Physiological effect Estrogen Antagonists Testing Estrogens, Non-Steroidal Congresses Molecular pharmacology Tamoxifen Tamoxifen Congresses Chemotherapie (DE-588)4127083-6 gnd Antiöstrogene (DE-588)4142728-2 gnd Krebs Medizin (DE-588)4073781-0 gnd Tumor (DE-588)4078460-5 gnd Brustkrebs (DE-588)4008528-4 gnd Inhibitor (DE-588)4027007-5 gnd |
| topic_facet | Anti-strogènes - Effets physiologiques Anti-strogènes - Essais Sein - Cancer - Chimiothérapie Tamoxifène Breast Neoplasms drug therapy Congresses Breast Cancer Endocrine aspects Estrogen Antagonists Congresses Estrogen Antagonists Physiological effect Estrogen Antagonists Testing Estrogens, Non-Steroidal Congresses Molecular pharmacology Tamoxifen Tamoxifen Congresses Chemotherapie Antiöstrogene Krebs Medizin Tumor Brustkrebs Inhibitor Konferenzschrift |
| volume_link | (DE-604)BV006663437 |
| work_keys_str_mv | AT sutherlandrobertl nonsteroidalantioestrogensmolecularpharmacologyandantitumouractivity |